ALBERT EINSTEIN COLLEGE OF MEDICINE
Identifying Collaborating Factors Driving DDX41 Mutant Pathology in MDS
Identifying Collaborating Factors Driving DDX41 Mutant Pathology in MDS is a funding opportunity from ALBERT EINSTEIN COLLEGE OF MEDICINE, up to 829319, closing November 30, 2030.
Nov 30, 2030
(1583d left)Overview
As we age, the efficiency of the hematopoietic system declines resulting in bone marrow failure symptoms in some individuals. Myelodysplastic syndromes (MDS) are disorders primarily affecting older adults and impact around 10,000 individuals annually in the United States. MDS arises due to dysfunction in hematopoietic…